Cipla�s
Did not found any latest news.
Interact & exchange stock tips & market info »
Related News »
Cipla 's shocking 75% price cut of three cancer drugs on Thursday is unlikely to have a major impact on the pharma major's earnings, analysts say. Cipla cut price of its kidney cancer drug Sorafenib, which is sold under brand name Nexavar by ...
May 16, 2012 at 10:23 | Source: MoneyControl.com
Cipla has posted a sharp 36.5 percent jump in net profit to Rs 292 crore for the March quarter compared to Rs 214 crore in the year-ago period. A CNBC TV-18 poll expected net profit to come in at Rs 295 crore. Revenues grew by 12.8 percent to ...
May 10, 2012 at 10:59 | Source: firstpost.com
Last year, Adcock Ingram submitted an application to the Pretoria High Court to have Cipla’s registration for its Zemax trademark revoked, arguing that it was too similar to Adcock Ingram’s Zetomax trademark, which was registered before Zemax.
May 24, 2012 at 22:17 | Source: Engineering News
Bayer says CIPLA’s new price "will render Natco’s price unreasonable and defeat the purpose of compulsory licensing," according to the newspaper. As that shows, there's been an interesting twist in this story. Cipla, another Indian ...
May 24, 2012 at 02:57 | Source: Tech Dirt
Cipla's decision to slash prices comes only weeks after India's patent authority forced Germany's Bayer AG to grant a license to another Indian generic drug producer for its kidney and liver cancer medicine Nexavar. The ruling, the first of its ...
May 4, 2012 at 12:25 | Source: Wall Street Journal
She says that this is a high-quality version of popular drugs by an Indian company, including Pfizer's Viagra -- Cipla's version is called Erecto. "The drug has become so popular with men, and we have to keep a good stock, because every day men stream in ...
May 27, 2012 at 12:34 | Source: AllAfrica.com
Cipla’s Lung & breast cancer drug Gestinib (sold under brand name Iressa by AstraZeneca for Rs 10,000/-) will cost Rs 4,250/-, while prices of is Temozolamide (sold by German pharma company Schering), used to treat brain tumor, have been cut from Rs ...
May 20, 2012 at 23:05 | Source: Vanguard
Y.K. Hamied, Cipla's chairman and managing director, said it's not mandatory to carry out final-stage trials in India for each and every new drug. For generic drugs, only bio-equivalence needs to be demonstrated, he added. The report named Cipla's ...
May 10, 2012 at 13:22 | Source: 4-traders (press release)
In the private sector the Aventis’s drug costs about twice as much Cipla’s generic. Mahapa said that in order to ensure that patients have access to Docetaxel, Aventis had launched a second brand at a price similar to Cipla Docetaxel, which would furth ...
May 16, 2012 at 05:37 | Source: Mail & Guardian Online
Pictures of nationalist leader Mahatma Gandhi, who visited the company in 1939, adorn Cipla's headquarters. Hamied said he did not enjoy a fight but would wage patent battles on principle, even when he knew the company was unlikely to recoup its costs in ...
May 17, 2012 at 04:31 | Source: in.news.yahoo.com